Showing results (81-90 of 1,068) with videos related to
Sort By:
Pageof 107
Journal of Pharmacokinetics and Pharmacodynamics|March 4, 2021
The power of modelling pulsatile profilesMichiel J van Esdonk, Jasper StevensJournal of Pharmacokinetics and Pharmacodynamics|June 14, 2008
Basic pharmacodynamic models for agents that alter the lifespan distribution of natural cellsWojciech Krzyzanski, Juan Jose Perez-Ruixo, An VermeulenJournal of Pharmacokinetics and Pharmacodynamics|April 6, 2019
Population pharmacokinetic reanalysis of a Diazepam PBPK model: a comparison of Stan and GNU MCSimPeriklis Tsiros, Frederic Y Bois, Aristides Dokoumetzidis, et al.Journal of Pharmacokinetics and Pharmacodynamics|July 24, 2012
Combining patient-level and summary-level data for Alzheimer's disease modeling and simulation: a β regression meta-analysisJames A Rogers, Daniel Polhamus, William R Gillespie, et al.Journal of Pharmacokinetics and Pharmacodynamics|July 14, 2012
Mechanism-based PK-PD model for the prolactin biological system response following an acute dopamine inhibition challenge: quantitative extrapolation to humansJasper Stevens, Bart A Ploeger, Margareta Hammarlund-Udenaes, et al.Journal of Pharmacokinetics and Pharmacodynamics|September 20, 2012
Modeling of Functional Assessment Questionnaire (FAQ) as continuous bounded data from the ADNI databaseK Ito, M M Hutmacher, B W CorriganJournal of Pharmacokinetics and Pharmacodynamics|June 28, 2012
From in vitro EC₅₀ to in vivo dose-response for antiretrovirals using an HIV disease model. Part I: a frameworkJing Fang, Pravin R JadhavJournal of Pharmacokinetics and Pharmacodynamics|September 7, 2004
Evaluation of type I error rates when modeling ordered categorical data in NONMEMUlrika Wählby, Katalin Matolcsi, Mats O Karlsson, et al.Journal of Pharmacokinetics and Pharmacodynamics|February 27, 2008
An alternative method for population pharmacokinetic data analysis under noncompliancePankaj Gupta, Matthew M Hutmacher, Bill Frame, et al.Journal of Pharmacokinetics and Pharmacodynamics|March 20, 2008
A model based assessment of the CYP2B6 and CYP2C19 inductive properties by artemisinin antimalarials: implications for combination regimensDoaa A Elsherbiny, Sara A Asimus, Mats O Karlsson, et al.Pageof 107